Italia markets closed

ILMN Jan 2025 270.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,38000,0000 (0,00%)
Alla chiusura: 03:32PM EDT
Schermo intero
Chiusura precedente2,3800
Aperto2,3800
Denaro0,0000
Lettera4,8000
Prezzo d'esercizio270,00
Scadenza2025-01-17
Min-Max giorno2,3800 - 2,3800
Contratto - Min-MaxN/D
Volume1
Open Interest102
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera